DOXORUBICINOL, THE METABOLITE OF DOXORUBUCIN, IS MORE CARDIOTOXIC THAN DOXORUBICIN

被引：13
作者：
BOUCEK, RJ
KUNKEL, EM
GRAHAM, TP
BRENNER, D
OLSON, RD
机构：
[1] VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT,NASHVILLE,TN 37232
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
[3] VET ADM MED CTR,BOISE,ID
来源：
PEDIATRIC RESEARCH | 1987年 / 21卷 / 04期
关键词：
D O I：
10.1203/00006450-198704010-00127
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：A187 / A187
页数：1
相关论文
共 50 条
[21]   β-hydroxybutyrate: Much more than a metabolite [J].
Newman, John C. ;
Verdin, Eric .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (02) :173-181
[22]   EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF DOXORUBICIN AND DOXORUBICINOL IN THE RABBIT [J].
CUSACK, BJ ;
TESNOHLIDEK, DA ;
LOSEKE, VL ;
VESTAL, RE ;
BRENNER, DE ;
OLSON, RD .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (04) :294-298
[23]   Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin [J].
Harahap, Yahdiana ;
Ardiningsih, Puspitasari ;
Winarti, Agatha Corintias ;
Purwanto, Denni Joko .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 :3469-3475
[24]   ALCOHOL PLUS COCAINE IS MORE CARDIOTOXIC THAN ALCOHOL OR COCAINE ALONE [J].
HENNING, RJ ;
WILSON, LD ;
GLAUSER, JM ;
SUTHEIMER, CA ;
LAVINS, E .
CLINICAL RESEARCH, 1993, 41 (02) :A384-A384
[25]   COCAINE PLUS ETHANOL IS MORE CARDIOTOXIC THAN COCAINE OR ETHANOL ALONE [J].
HENNING, RJ ;
WILSON, LD ;
GLAUSER, JM .
CRITICAL CARE MEDICINE, 1994, 22 (12) :1896-1906
[26]   DOXORUBICIN AND DOXORUBICINOL - INTRAINDIVIDUAL AND INTERINDIVIDUAL VARIATIONS OF PHARMACOKINETIC PARAMETERS [J].
JACQUET, JM ;
BRESSOLLE, F ;
GALTIER, M ;
BOURRIER, M ;
DONADIO, D ;
JOURDAN, J ;
ROSSI, JF .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 27 (03) :219-225
[27]   COMPARATIVE ACTIVITY OF DOXORUBICIN AND ITS MAJOR METABOLITE, DOXORUBICINOL, ON V79/AP4 FIBROBLASTS - A MORPHOFUNCTIONAL STUDY [J].
BERNARDINI, N ;
GIANNESSI, F ;
BIANCHI, F ;
DOLFI, A ;
LUPETTI, M ;
ZACCARO, L ;
MALVALDI, G ;
DELTACCA, M .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1991, 55 (03) :238-250
[28]   CELLULAR PHARMACOLOGY OF DOXORUBICIN OR ITS METABOLITE DOXORUBICINOL COMBINED WITH VERAPAMIL IN SENSITIVE AND RESISTANT PANCREATIC-CANCER CELL-LINES [J].
CHANG, BK ;
BRENNER, DE .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 :394-394
[29]   Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE [J].
Sottani, Cristina ;
Poggi, Guido ;
Melchiorre, Fabio ;
Montagna, Benedetta ;
Minoia, Claudio .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2013, 915 :71-78
[30]   FLUOROURACIL AND DOXORUBICIN - CARDIOTOXIC CYTOSTATICS IN THE WORKPLACE [J].
Kupczewska-Dobecka, Malgorzata ;
Czerczak, Slawomir .
MEDYCYNA PRACY, 2020, 71 (03) :363-373
12345